Periodic Reporting for period 1 - OMICSENS (integrated nano-photonic OMICs bio-SENSor for lung cancer)

OMICSENS is creating a groundbreaking platform to revolutionize cancer diagnostics, starting with non-small cell lung cancer (NSCLC). Its goal is to detect resistance to Tyrosine Kinase Inhibitors (TKIs) caused by mutations in the Epidermal Growth Factor Receptor (EGFR)...